National Institutes of Health

[Entry Page]
[11 Mar 2004]
[10 Mar 2004]
[9 Mar 2004]
[4 Dec 2003]
[3 Dec 2003]
[17 Oct 2003]
[17 Sept 2003]
[19 June 2003]
[18 June 2003]
[6-7 Mar 2003]
[4-6 Dec 2002]
[20-21 June 2002]
[7-8 Mar 2002]
[7-8 Dec 2001]
[06 Dec 2001]

Recombinant DNA Advisory Committee (RAC)
91st Meeting of the NIH RAC

Bethesda Marriot Hotel
Bethesda, Maryland
June 18-19 2003

Thursday, June 19, 2003

Powerpoint Slides

588 Carter Powerpoint Slides
588 Evans Powerpoint Slides
588 TNFR RAC Pub Powerpoint Slides

594 Carter Powerpoint Slides
594 Tissue Gene

8.30 AM    Call to Order and Opening Remarks
Theodore Friedmann, M.D., Chair, NIH RAC

8:35 AM    Informed Consent

                 What Consent Forms Say and What Researchers and Subjects                           Expect in Gene Therapy Research
    Nancy M.P. King, J.D., and Gail Henderson, Ph.D., University of North                    Carolina, Chapel Hill
                 Powerpoint Slides

9:35 AM    Discussion

9:50 AM    BREAK

10:05 AM NIH RAC Informed Consent Working Group (ICWG) Drraft                            Guidance
Nancy M.P. King, J.D., and Baruch Brody, Ph.D., Cochairs,

                 Tab 2304                                                     

                   RAC ICWG Members:     James Childress, Ph.D.
                                                             Bernard Lo, M.D.
                                                             Diane Wara, M.D.
                   U.S. Department of Health and Human Services (DHHS) ICWG                                Members:
                              Suzanne Goodwin, OBA
                                                             Allan Shipp, OBA
                                                             Stephen Rose, Ph.D., OBA
                                                             Kristina Borror, Ph.D., Office for Human                                                                    Research Protections, DHHS
                                                             Cynthia Rask, M.D., U.S. Food and Drug                                                                  Administration

10:35 AM       Discussion

11:35 AM       Public Comment



This webcast produced by